196 related articles for article (PubMed ID: 26172393)
1. Phosphorylation of apoptosis repressor with caspase recruitment domain by protein kinase CK2 contributes to chemotherapy resistance by inhibiting doxorubicin induced apoptosis.
Wang J; Feng C; He Y; Ding W; Sheng J; Arshad M; Zhang X; Li P
Oncotarget; 2015 Sep; 6(29):27700-13. PubMed ID: 26172393
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis repressor with caspase recruitment domain contributes to chemotherapy resistance by abolishing mitochondrial fission mediated by dynamin-related protein-1.
Wang JX; Li Q; Li PF
Cancer Res; 2009 Jan; 69(2):492-500. PubMed ID: 19147562
[TBL] [Abstract][Full Text] [Related]
3. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
Izeradjene K; Douglas L; Delaney A; Houghton JA
Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
[TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis by antisense CK2 in human prostate cancer xenograft model.
Slaton JW; Unger GM; Sloper DT; Davis AT; Ahmed K
Mol Cancer Res; 2004 Dec; 2(12):712-21. PubMed ID: 15634760
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of catalase and oxidative modification of protein kinase CK2 lead to the failure of apoptosis repressor with caspase recruitment domain to inhibit cardiomyocyte hypertrophy.
Murtaza I; Wang HX; Feng X; Alenina N; Bader M; Prabhakar BS; Li PF
J Biol Chem; 2008 Mar; 283(10):5996-6004. PubMed ID: 18171680
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-532-3p regulates mitochondrial fission through targeting apoptosis repressor with caspase recruitment domain in doxorubicin cardiotoxicity.
Wang JX; Zhang XJ; Feng C; Sun T; Wang K; Wang Y; Zhou LY; Li PF
Cell Death Dis; 2015 Mar; 6(3):e1677. PubMed ID: 25766316
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation by protein kinase CK2: a signaling switch for the caspase-inhibiting protein ARC.
Li PF; Li J; Müller EC; Otto A; Dietz R; von Harsdorf R
Mol Cell; 2002 Aug; 10(2):247-58. PubMed ID: 12191471
[TBL] [Abstract][Full Text] [Related]
8. Characterizing the convergence of protein kinase CK2 and caspase-3 reveals isoform-specific phosphorylation of caspase-3 by CK2α': implications for pathological roles of CK2 in promoting cancer cell survival.
Turowec JP; Vilk G; Gabriel M; Litchfield DW
Oncotarget; 2013 Apr; 4(4):560-71. PubMed ID: 23599180
[TBL] [Abstract][Full Text] [Related]
9. Systemic administration of antisense oligonucleotides simultaneously targeting CK2α and α' subunits reduces orthotopic xenograft prostate tumors in mice.
Trembley JH; Unger GM; Tobolt DK; Korman VL; Wang G; Ahmad KA; Slaton JW; Kren BT; Ahmed K
Mol Cell Biochem; 2011 Oct; 356(1-2):21-35. PubMed ID: 21761204
[TBL] [Abstract][Full Text] [Related]
10. VCPA, a novel synthetic derivative of α-tocopheryl succinate, sensitizes human gastric cancer to doxorubicin-induced apoptosis via ROS-dependent mitochondrial dysfunction.
Wu H; Liu S; Gong J; Liu J; Zhang Q; Leng X; Zhang N; Li Y
Cancer Lett; 2017 May; 393():22-32. PubMed ID: 28216375
[TBL] [Abstract][Full Text] [Related]
11. Novel cardiac apoptotic pathway: the dephosphorylation of apoptosis repressor with caspase recruitment domain by calcineurin.
Tan WQ; Wang JX; Lin ZQ; Li YR; Lin Y; Li PF
Circulation; 2008 Nov; 118(22):2268-76. PubMed ID: 19001025
[TBL] [Abstract][Full Text] [Related]
12. A Selective Biligand Inhibitor of CK2 Increases Caspase-3 Activity in Cancer Cells and Inhibits Platelet Aggregation.
Rahnel H; Viht K; Lavogina D; Mazina O; Haljasorg T; Enkvist E; Uri A
ChemMedChem; 2017 Oct; 12(20):1723-1736. PubMed ID: 28837260
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of protein kinase CK2 by CX-5011 counteracts imatinib-resistance preventing rpS6 phosphorylation in chronic myeloid leukaemia cells: new combined therapeutic strategies.
Salizzato V; Borgo C; Cesaro L; Pinna LA; Donella-Deana A
Oncotarget; 2016 Apr; 7(14):18204-18. PubMed ID: 26919095
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological inhibition of protein kinase CK2 reverts the multidrug resistance phenotype of a CEM cell line characterized by high CK2 level.
Di Maira G; Brustolon F; Bertacchini J; Tosoni K; Marmiroli S; Pinna LA; Ruzzene M
Oncogene; 2007 Oct; 26(48):6915-26. PubMed ID: 17486073
[TBL] [Abstract][Full Text] [Related]
15. Casein kinase 2 regulates both apoptosis and the cell cycle following DNA damage induced by 6-thioguanine.
Yamane K; Kinsella TJ
Clin Cancer Res; 2005 Mar; 11(6):2355-63. PubMed ID: 15788687
[TBL] [Abstract][Full Text] [Related]
16. Casein kinase 2α regulates multidrug resistance-associated protein 1 function via phosphorylation of Thr249.
Stolarczyk EI; Reiling CJ; Pickin KA; Coppage R; Knecht MR; Paumi CM
Mol Pharmacol; 2012 Sep; 82(3):488-99. PubMed ID: 22695718
[TBL] [Abstract][Full Text] [Related]
17. Decreased apoptosis repressor with caspase recruitment domain confers resistance to sunitinib in renal cell carcinoma through alternate angiogenesis pathways.
Gobe GC; Ng KL; Small DM; Vesey DA; Johnson DW; Samaratunga H; Oliver K; Wood S; Barclay JL; Rajandram R; Li L; Morais C
Biochem Biophys Res Commun; 2016 Apr; 473(1):47-53. PubMed ID: 26995091
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis repressor with caspase recruitment domain is regulated by MAPK/PI3K and confers drug resistance and survival advantage to AML.
Mak PY; Mak DH; Mu H; Shi Y; Ruvolo P; Ruvolo V; Jacamo R; Burks JK; Wei W; Huang X; Kornblau SM; Andreeff M; Carter BZ
Apoptosis; 2014 Apr; 19(4):698-707. PubMed ID: 24337870
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen sulfide protects cardiomyocytes from myocardial ischemia-reperfusion injury by enhancing phosphorylation of apoptosis repressor with caspase recruitment domain.
Yao X; Tan G; He C; Gao Y; Pan S; Jiang H; Zhang Y; Sun X
Tohoku J Exp Med; 2012 Apr; 226(4):275-85. PubMed ID: 22499119
[TBL] [Abstract][Full Text] [Related]
20. CK2-mediated CCDC106 phosphorylation is required for p53 degradation in cancer progression.
Ning Y; Wang C; Liu X; Du Y; Liu S; Liu K; Zhou J; Zhou C
J Exp Clin Cancer Res; 2019 Mar; 38(1):131. PubMed ID: 30885251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
